Controlled Substances Security Act - Sets forth the findings of Congress.
Directs the Attorney General to establish security standards for manufacturers to observe in the storage, shipment, and delivery of drugs listed in schedule II of the Controlled Substances Act.
Authorizes the Attorney General or his designate to enter any place of manufacture of a drug with respect to which standards are established to assure that the standards are being observed.
Requires the registration suspension of a manufacturer of a drug with respect to which any substantial quantity has been lost during any storage, shipment, or delivery of the drug by the manufacturer.
Terminates the registration, after a hearing, for six months where the Attorney General finds that a manufacturer failed to observe the standards of this Act, such periods of termination to be cumulative rather than concurrent.
Introduced in House
Introduced in House
Referred to House Committee on Interstate and Foreign Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line